Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM-EZ Study.
about
Paget's Disease: Skeletal Manifestations and Effect of Bisphosphonates.Antibody Response to Paramyxoviruses in Paget's Disease of BoneBisphosphonates for Paget's disease of bone in adults.Treating Paget's Disease-Why and How Much?Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62 mouse model of Paget's disease
P2860
Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM-EZ Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Long-Term Randomized Trial of ...... e of Bone: The PRISM-EZ Study.
@en
Long-Term Randomized Trial of ...... e of Bone: The PRISM-EZ Study.
@nl
type
label
Long-Term Randomized Trial of ...... e of Bone: The PRISM-EZ Study.
@en
Long-Term Randomized Trial of ...... e of Bone: The PRISM-EZ Study.
@nl
prefLabel
Long-Term Randomized Trial of ...... e of Bone: The PRISM-EZ Study.
@en
Long-Term Randomized Trial of ...... e of Bone: The PRISM-EZ Study.
@nl
P2093
P2860
P356
P1476
Long-Term Randomized Trial of ...... e of Bone: The PRISM-EZ Study.
@en
P2093
Adrian Tan
Allan Walker
Graeme S MacLennan
Jemma Hudson
Kirsteen Goodman
PRISM-EZ Trial Group
Stuart H Ralston
William D Fraser
P2860
P304
P356
10.1002/JBMR.3066
P50
P577
2017-02-08T00:00:00Z